Conclusions: Our data suggest that the CX3CR1/CX3CL1 axis is activated in CLL and may contribute to the NLC-driven growth-promoting effects of CLL cells. The gene discussed is CX3CR1; the disease is B-cell chronic lymphocytic leukemia.